Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaitonde

Showing results (211-220 of 260) with videos related to

Pageof 26
Sort By:
Urologic Oncology|December 3, 2014
Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary resultsBishoy A Gayed, Aditya Bagrodia, Mansi Gaitonde, et al.
Transplantation Proceedings|February 21, 2023
Desensitizing With Temporary Donor Splenic Transplant: Hope for the Sensitized Patients on Pancreas and Kidney -Pancreas Transplant WaitlistPierpaolo Di Cocco, Sujata Gaitonde, Mario Spaggiari, et al.
Clinical Drug Investigation|July 17, 2023
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with OsteoarthritisMark T Brown, David R Cornblath, Martin Koltzenburg, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertensionRobyn J Barst, Dunbar Ivy, Jasper Dingemanse, et al.
Human Immunology|December 18, 2025
Increasing the liver donation pool: Eculizumab desensitization for ABO-incompatible living donor liver transplantation - A case seriesMario Spaggiari, Maria Jimena Alaniz, Elif Kortan, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and RecommendationsJennifer Taylor, Sagar Patel, Krishnanath Gaitonde, et al.
The Journal of Pathology|February 1, 1991
Oncoprotein immunoreactivity in human endocrine tumoursM Roncalli, D R Springall, I M Varndell, et al.
Echocardiography (Mount Kisco, N.Y.)|July 27, 2007
Stress-induced wall motion abnormalities with low-dose dobutamine infusion indicate the presence of severe disease and vulnerable myocardiumStephen G Sawada, Anas Safadi, Rajdeep S Gaitonde, et al.
Journal of Biomolecular Screening|July 8, 2003
Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphataseTammy C Turek-Etienne, Eliza C Small, Sharon C Soh, et al.
Carcinogenesis|September 15, 2010
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancerZhongyun Dong, Yin Liu, Kieran F Scott, et al.
Pageof 26

Showing results (211-220 of 260) with videos related to

Sort By:
Pageof 26
Urologic Oncology|December 3, 2014
Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary resultsBishoy A Gayed, Aditya Bagrodia, Mansi Gaitonde, et al.
Transplantation Proceedings|February 21, 2023
Desensitizing With Temporary Donor Splenic Transplant: Hope for the Sensitized Patients on Pancreas and Kidney -Pancreas Transplant WaitlistPierpaolo Di Cocco, Sujata Gaitonde, Mario Spaggiari, et al.
Clinical Drug Investigation|July 17, 2023
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with OsteoarthritisMark T Brown, David R Cornblath, Martin Koltzenburg, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertensionRobyn J Barst, Dunbar Ivy, Jasper Dingemanse, et al.
Human Immunology|December 18, 2025
Increasing the liver donation pool: Eculizumab desensitization for ABO-incompatible living donor liver transplantation - A case seriesMario Spaggiari, Maria Jimena Alaniz, Elif Kortan, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and RecommendationsJennifer Taylor, Sagar Patel, Krishnanath Gaitonde, et al.
The Journal of Pathology|February 1, 1991
Oncoprotein immunoreactivity in human endocrine tumoursM Roncalli, D R Springall, I M Varndell, et al.
Echocardiography (Mount Kisco, N.Y.)|July 27, 2007
Stress-induced wall motion abnormalities with low-dose dobutamine infusion indicate the presence of severe disease and vulnerable myocardiumStephen G Sawada, Anas Safadi, Rajdeep S Gaitonde, et al.
Journal of Biomolecular Screening|July 8, 2003
Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphataseTammy C Turek-Etienne, Eliza C Small, Sharon C Soh, et al.
Carcinogenesis|September 15, 2010
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancerZhongyun Dong, Yin Liu, Kieran F Scott, et al.
Pageof 26